Thomas C. Dowling

2.2k total citations
66 papers, 1.6k citations indexed

About

Thomas C. Dowling is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Thomas C. Dowling has authored 66 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Nephrology, 11 papers in Cardiology and Cardiovascular Medicine and 11 papers in Oncology. Recurrent topics in Thomas C. Dowling's work include Drug Transport and Resistance Mechanisms (10 papers), Pharmacogenetics and Drug Metabolism (9 papers) and Chronic Kidney Disease and Diabetes (9 papers). Thomas C. Dowling is often cited by papers focused on Drug Transport and Resistance Mechanisms (10 papers), Pharmacogenetics and Drug Metabolism (9 papers) and Chronic Kidney Disease and Diabetes (9 papers). Thomas C. Dowling collaborates with scholars based in United States, Ireland and United Kingdom. Thomas C. Dowling's co-authors include Chetan S. Karyekar, Reginald F. Frye, Natalie D. Eddington, Ayse L. Mindikoglu, Stephen L. Seliger, John D. Sorkin, Luigi Ferrucci, Robert H. Christenson, Laurence S. Magder and Stephen S. Gottlieb and has published in prestigious journals such as Circulation, Gastroenterology and PLoS ONE.

In The Last Decade

Thomas C. Dowling

64 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas C. Dowling United States	23	396	371	230	202	188	66	1.6k
Stefan Russmann Switzerland	26	125 0.3×	240 0.6×	353 1.5×	328 1.6×	276 1.5×	64	2.2k
Richard A. Robson New Zealand	29	225 0.6×	348 0.9×	489 2.1×	142 0.7×	388 2.1×	87	2.8k
G. Schumann Germany	24	158 0.4×	610 1.6×	324 1.4×	96 0.5×	108 0.6×	65	2.5k
Atef Halabi Germany	25	805 2.0×	147 0.4×	169 0.7×	88 0.4×	221 1.2×	79	2.2k
Abdul H. Khan United States	29	383 1.0×	133 0.4×	233 1.0×	66 0.3×	593 3.2×	129	2.5k
Vladimír Palička Czechia	28	312 0.8×	139 0.4×	354 1.5×	62 0.3×	359 1.9×	217	3.4k
Ingegerd Odar‐Cederlöf Sweden	23	195 0.5×	260 0.7×	167 0.7×	44 0.2×	218 1.2×	53	1.7k
Diane K. Jorkasky United States	27	425 1.1×	61 0.2×	203 0.9×	86 0.4×	139 0.7×	68	1.7k
Juan J.L. Lertora United States	24	199 0.5×	67 0.2×	222 1.0×	114 0.6×	185 1.0×	49	1.7k
Consuelo Huerta Spain	22	361 0.9×	76 0.2×	260 1.1×	45 0.2×	237 1.3×	66	2.3k

Countries citing papers authored by Thomas C. Dowling

Since Specialization

Citations

This map shows the geographic impact of Thomas C. Dowling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas C. Dowling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas C. Dowling more than expected).

Fields of papers citing papers by Thomas C. Dowling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas C. Dowling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas C. Dowling. The network helps show where Thomas C. Dowling may publish in the future.

Co-authorship network of co-authors of Thomas C. Dowling

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas C. Dowling. A scholar is included among the top collaborators of Thomas C. Dowling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas C. Dowling. Thomas C. Dowling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gerlach, Anthony T., et al.. (2022). Performance of different body weights in the Cockcroft‐Gault equation in critically ill patients with and without augmented renal clearance: A multicenter cohort. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 43(11). 1131–1138. 7 indexed citations

Kharel, Madan K., et al.. (2022). Upcycling the anthracyclines: New mechanisms of action, toxicology, and pharmacology. Toxicology and Applied Pharmacology. 459. 116362–116362. 22 indexed citations

Martinez, Marilyn N., Bipin Mistry, Kimberley A. Lentz, et al.. (2017). Exploring Canine-Human Differences in Product Performance. Part II: Use of Modeling and Simulation to Explore the Impact of Formulation on Ciprofloxacin In Vivo Absorption and Dissolution in Dogs. The AAPS Journal. 19(3). 712–726. 4 indexed citations

Medina-Moreno, Sandra, Thomas C. Dowling, Juan Carlos Zapata, et al.. (2017). Targeting of CDK9 with indirubin 3’-monoxime safely and durably reduces HIV viremia in chronically infected humanized mice. PLoS ONE. 12(8). e0183425–e0183425. 16 indexed citations

Gray, Ewan, et al.. (2016). Direct costs of interferon‐based and interferon‐free direct‐acting antiviral regimens for the treatment of chronic hepatitis C infection. Journal of Viral Hepatitis. 23(9). 677–686. 4 indexed citations

Heil, Emily L., et al.. (2015). Validation of a Dosing Strategy for Cefazolin for Surgery Requiring Cardiopulmonary Bypass. Surgical Infections. 16(6). 829–832. 8 indexed citations

Mindikoglu, Ayse L., Thomas C. Dowling, Laurence S. Magder, et al.. (2015). Estimation of Glomerular Filtration Rate in Patients With Cirrhosis by Using New and Conventional Filtration Markers and Dimethylarginines. Clinical Gastroenterology and Hepatology. 14(4). 624–632.e2. 26 indexed citations

Haidar, Sam, Xinyuan Zhang, Wenlei Jiang, et al.. (2015). Effect of Common Excipients on the Oral Drug Absorption of Biopharmaceutics Classification System Class 3 Drugs Cimetidine and Acyclovir. Journal of Pharmaceutical Sciences. 105(2). 996–1005. 49 indexed citations

Volpe, Donna A., Anne‐Marie Tobin, Fatemeh Tavakkoli, et al.. (2013). Effect of uremic serum and uremic toxins on drug metabolism in human microsomes. Regulatory Toxicology and Pharmacology. 68(2). 297–303. 29 indexed citations

10.

Cai, Ling, et al.. (2012). Optimum Ribavirin Exposure Overcomes Racial Disparity in Efficacy of Peginterferon and Ribavirin Treatment for Hepatitis C Genotype 1. The American Journal of Gastroenterology. 107(11). 1675–1683. 13 indexed citations

11.

Denetclaw, Tina Harrach, et al.. (2011). Dofetilide Dose Calculation Errors in Elderly Associated with Use of the Modification of Diet in Renal Disease Equation. Annals of Pharmacotherapy. 45(7-8). 1029–1029. 11 indexed citations

12.

Dowling, Thomas C., Gary R. Matzke, John E. Murphy, & Gilbert J. Burckart. (2010). Evaluation of Renal Drug Dosing: Prescribing Information and Clinical Pharmacist Approaches. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 30(8). 776–786. 53 indexed citations

13.

Howell, Charles D., Thomas C. Dowling, Abdus S. Wahed, et al.. (2008). Peginterferon Pharmacokinetics in African American and Caucasian American Patients With Hepatitis C Virus Genotype 1 Infection. Clinical Gastroenterology and Hepatology. 6(5). 575–583. 24 indexed citations

14.

Rogers, Hobart, Joanne Marshall, Jeremy S. Bock, et al.. (2008). A Randomized, Controlled Trial of the Renal Effects of Ultrafiltration as Compared to Furosemide in Patients With Acute Decompensated Heart Failure. Journal of Cardiac Failure. 14(1). 1–5. 76 indexed citations

15.

Dittrich, Howard C., et al.. (2007). The Effect of KW-3902, an Adenosine A1 Receptor Antagonist, on Renal Function and Renal Plasma Flow in Ambulatory Patients With Heart Failure and Renal Impairment. Journal of Cardiac Failure. 13(8). 609–617. 76 indexed citations

16.

Brown, J. Scott, et al.. (2007). Urinary cotinine as an objective measure of cigarette smoking in chronic kidney disease. Nephrology Dialysis Transplantation. 22(7). 1950–1954. 16 indexed citations

17.

Iqbal, Tahira, et al.. (2003). Validation of a simplified method for determination of cimetidine in human plasma and urine by liquid chromatography with ultraviolet detection. Journal of Chromatography B. 799(2). 337–341. 28 indexed citations

18.

Raje, Sangeeta, Thomas C. Dowling, & Natalie D. Eddington. (2002). Determination of the benztropine analog AHN-1055, a dopamine uptake inhibitor, in rat plasma and brain by high-performance liquid chromatography with ultraviolet absorbance detection. Journal of Chromatography B. 768(2). 305–313. 12 indexed citations

19.

Dowling, Thomas C., et al.. (1999). Comparison of Iothalamate Clearance Methods for Measuring GFR. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 19(8). 943–950. 21 indexed citations

20.

Dowling, Thomas C., Reginald F. Frye, & Michael A. Zemaitis. (1998). Simultaneous determination of p-aminohippuric acid, acetyl-p-aminohippuric acid and iothalamate in human plasma and urine by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 716(1-2). 305–313. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact